Targeted molecular therapy for Myocardial Infarction: ARF inhibits myocardial function after myocardial infarction via up regulation of its target gene, 29/August/2014, 21.07

Targeted molecular therapy for Myocardial Infarction: ARF inhibits myocardial function after myocardial infarction via up regulation of its target gene, 29/August/2014, 21.07

Targeted molecular therapy for Myocardial Infarction: ARF inhibits myocardial function after myocardial infarction via up regulation of its target gene, 29/August/2014, 21.07 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Targeted molecular therapy for Myocardial Infarction: ARF inhibits  myocardial function after myocardial infarction via up regulation of its target gene, 29/August/2014, 21.07, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org.

Significance: This study suggests that ARF, by increasing the expression of its target gene, it may inhibit myocardial function.    Furthermore, this study suggests that pharmacological formulations encompassing “ARF inhibitor” may inhibit myocardial infarction.